EuroPCR 2022 | The MITRA TUNE Registry

Left atrial enlargement with or without atrial fibrillation (AF), absence of valvular degeneration, and heart failure with preserved function have recently been identified as functional atrial mitral regurgitation (MR). This subtype of secondary MR currently appears to be underdiagnosed, and the need for treatment in the general population might be greater than predicted.

The MITRA TUNE Registry

The aim of this multicenter study was to analyze the 30-day and 2-year clinical and echocardiographic outcomes of patients who underwent transcatheter mitral valve repair.

Inclusion criteria were functional mitral insufficiency 3+/4+, LV diastolic diameter <55 without motility disorders; persistent, permanent, or paroxysmal AF, and normal valvular structure. 

Of the 1135 patients, 87 met the inclusion criteria. Mean patient age was 81 years old, and most subjects were female (61%). The Society of Thoracic Surgeons (STS) score was 4%. Technical success was 97%. The in-hospital death rate was 2%, the acute renal failure rate was 8%, and the major bleeding rate was 4.5%. At 30 days, the total mortality rate was 5% and the rate for cardiovascular death was 4%.

Mild or moderate MR was present in 98% of patients, and symptomatic improvement was observed in 79% of patients with functional class I/II within the first year of follow-up.

Echocardiographic analysis of the left atrium showed significant positive remodeling compared with baseline values and control outcomes within the first year. 

Read also: DISCO RADIAL: Conventional or Distal Transradial Access?

The rate for cardiovascular survival and hospitalization for heart failure in these patients was 55% at 2 years. A multivariate analysis showed that postprocedural MI ≥2+ and intercommissural annular diameter ≥35 mm were independent negative predictors.

Conclusion

In patients with functional atrial MR, transcatheter edge-to-edge repair of the mitral valve was shown to be safe and effective, inducing positive reverse remodeling of the left atrium and mitral annulus, improving symptoms.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez
Member of the Editorial Board of SOLACI.org.

Original Title: MItraClip in Atrial Functional mitral regurgitation: a multi-center experience. The MITRA TUNE Registry. 

Reference: Antonio Popolo Rubbio, et al. EUROPCR.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....